Literature DB >> 21836076

Polyclonal immunoglobulin free light chains as a potential biomarker of immune stimulation and inflammation.

Colin A Hutchison1, Ola Landgren.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21836076      PMCID： PMC7020668          DOI： 10.1373/clinchem.2011.169433

Source DB:  PubMed          Journal:  Clin Chem        ISSN： 0009-9147            Impact factor:   8.327


× No keyword cloud information.
  11 in total

1.  Highly sensitive, automated immunoassay for immunoglobulin free light chains in serum and urine.

Authors:  A R Bradwell; H D Carr-Smith; G P Mead; L X Tang; P J Showell; M T Drayson; R Drew
Journal:  Clin Chem       Date:  2001-04       Impact factor: 8.327

2.  Light chains of human immunoglobulins.

Authors:  A Solomon
Journal:  Methods Enzymol       Date:  1985       Impact factor: 1.600

3.  The renal handling of low molecular weight proteins. II. Disorders of serum protein catabolism in patients with tubular proteinuria, the nephrotic syndrome, or uremia.

Authors:  T A Waldmann; W Strober; R P Mogielnicki
Journal:  J Clin Invest       Date:  1972-08       Impact factor: 14.808

4.  C-reactive protein and the risk of incident colorectal cancer.

Authors:  Thomas P Erlinger; Elizabeth A Platz; Nader Rifai; Kathy J Helzlsouer
Journal:  JAMA       Date:  2004-02-04       Impact factor: 56.272

5.  Evidence of serum immunoglobulin abnormalities up to 9.8 years before diagnosis of chronic lymphocytic leukemia: a prospective study.

Authors:  Huei-Ting Tsai; Neil E Caporaso; Robert A Kyle; Jerry A Katzmann; Angela Dispenzieri; Richard B Hayes; Gerald E Marti; Maher Albitar; Paolo Ghia; S Vincent Rajkumar; Ola Landgren
Journal:  Blood       Date:  2009-10-14       Impact factor: 22.113

6.  Quantitative assessment of serum and urinary polyclonal free light chains in patients with chronic kidney disease.

Authors:  Colin A Hutchison; Stephen Harding; Pete Hewins; Graham P Mead; John Townsend; Arthur R Bradwell; Paul Cockwell
Journal:  Clin J Am Soc Nephrol       Date:  2008-11       Impact factor: 8.237

Review 7.  The evolving use of serum free light chain assays in haematology.

Authors:  Guy Pratt
Journal:  Br J Haematol       Date:  2008-03-03       Impact factor: 6.998

8.  Circulating serum free light chains as predictive markers of AIDS-related lymphoma.

Authors:  Ola Landgren; James J Goedert; Charles S Rabkin; Wyndham H Wilson; Kieron Dunleavy; Robert A Kyle; Jerry A Katzmann; S Vincent Rajkumar; Eric A Engels
Journal:  J Clin Oncol       Date:  2010-01-04       Impact factor: 44.544

Review 9.  International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders.

Authors:  A Dispenzieri; R Kyle; G Merlini; J S Miguel; H Ludwig; R Hajek; A Palumbo; S Jagannath; J Blade; S Lonial; M Dimopoulos; R Comenzo; H Einsele; B Barlogie; K Anderson; M Gertz; J L Harousseau; M Attal; P Tosi; P Sonneveld; M Boccadoro; G Morgan; P Richardson; O Sezer; M V Mateos; M Cavo; D Joshua; I Turesson; W Chen; K Shimizu; R Powles; S V Rajkumar; B G M Durie
Journal:  Leukemia       Date:  2008-11-20       Impact factor: 11.528

10.  C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis.

Authors:  Stephen Kaptoge; Emanuele Di Angelantonio; Gordon Lowe; Mark B Pepys; Simon G Thompson; Rory Collins; John Danesh
Journal:  Lancet       Date:  2009-12-22       Impact factor: 79.321
View more
  17 in total

1.  Circulating antibody free light chains and risk of posttransplant lymphoproliferative disorder.

Authors:  E A Engels; J Preiksaitis; A Zingone; O Landgren
Journal:  Am J Transplant       Date:  2012-02-02       Impact factor: 8.086

2.  MGUS prevalence in a cohort of AML patients.

Authors:  S Peter Wu; Rene Costello; Jonathan N Hofmann; Neha Korde; Sham Mailankody; Mark Purdue; Ola Landgren
Journal:  Blood       Date:  2013-07-11       Impact factor: 22.113

3.  Serum immunoglobulin free light chain levels in systemic autoimmune rheumatic diseases.

Authors:  F Gulli; C Napodano; M Marino; G Ciasca; K Pocino; V Basile; M Visentini; A Stefanile; L Todi; M De Spirito; G L Rapaccini; U Basile
Journal:  Clin Exp Immunol       Date:  2019-10-31       Impact factor: 4.330

4.  Urinary free light chains may help to identify infection in patients with elevated systemic inflammation due to rheumatic disease.

Authors:  Carsten P Bramlage; Britta Froelich; Manuel Wallbach; Joan Minguet; Clemens Grupp; Cornelia Deutsch; Peter Bramlage; Gerhard A Müller; Michael Koziolek
Journal:  Rheumatol Int       Date:  2017-02-18       Impact factor: 2.631

5.  B cell homeostasis is maintained during long-duration spaceflight.

Authors:  Guillaume Spielmann; Nadia Agha; Hawley Kunz; Richard J Simpson; Brian Crucian; Satish Mehta; Mitzi Laughlin; John Campbell
Journal:  J Appl Physiol (1985)       Date:  2018-11-29

6.  The significance and predictive value of free light chains in the urine of patients with chronic inflammatory rheumatic disease.

Authors:  Carsten Paul Bramlage; Britta Froelich; Manuel Wallbach; Joan Minguet; Clemens Grupp; Cornelia Deutsch; Peter Bramlage; Michael Koziolek; Gerhard Anton Müller
Journal:  Clin Rheumatol       Date:  2016-10-12       Impact factor: 2.980

7.  Free light chains and the risk of AIDS-defining opportunistic infections in HIV-infected individuals.

Authors:  Meredith S Shiels; Ola Landgren; Rene Costello; Adriana Zingone; James J Goedert; Eric A Engels
Journal:  Clin Infect Dis       Date:  2012-08-14       Impact factor: 9.079

8.  Agent Orange Exposure and Monoclonal Gammopathy of Undetermined Significance: An Operation Ranch Hand Veteran Cohort Study.

Authors:  Ola Landgren; Youn K Shim; Joel Michalek; Rene Costello; Debra Burton; Norma Ketchum; Katherine R Calvo; Neil Caporaso; Elizabeth Raveche; Dan Middleton; Gerald Marti; Robert F Vogt
Journal:  JAMA Oncol       Date:  2015-11       Impact factor: 31.777

9.  Polyclonal free light chains: a biomarker of inflammatory disease or treatment target?

Authors:  Judith A Brebner; Robert A Stockley
Journal:  F1000 Med Rep       Date:  2013-02-01

10.  The Association between Polyclonal Combined Serum Free Light Chain Concentration and Mortality in Individuals with Early Chronic Kidney Disease.

Authors:  Lakhvir K Assi; Natasha McIntyre; Simon Fraser; Scott Harris; Colin A Hutchison; Chris W McIntyre; Paul Cockwell; Maarten W Taal
Journal:  PLoS One       Date:  2015-07-01       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.